GEODE CAPITAL MANAGEMENT, LLC

Position in CALC — CalciMedica, Inc.

CIK 1214717 BOSTON, MA

Position in CALC

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$66,625

-$590,970 QoQ

Shares Held

123,382

+23.6% QoQ

Ownership

0.781%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. CALC ranks #479 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,139,621	$2,741,586,360
2	REGN	Regeneron Pharmaceuticals, Inc.	2,607,732	$2,014,838,051
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,660,385	$880,241,584
4	INSM	INSMED Inc	4,450,389	$727,727,608
5	MRNA	Moderna, Inc.	9,435,132	$479,304,705
6	INCY	Incyte Corp	4,703,184	$442,663,677
7	RPRX	Royalty Pharma plc	7,869,632	$377,506,246
8	BBIO	BridgeBio Pharma, Inc.	4,918,030	$365,212,906

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$66,625	123,382	+23.6%	Shares	Defined	2026-05-15
2025-12-31	$657,595	99,787	+0.9%	Shares	Defined	2026-02-09
2025-09-30	$304,068	98,852	+1.9%	Shares	Defined	2025-11-12
2025-06-30	$155,250	97,032	+0.7%	Shares	Defined	2025-08-08
2025-03-31	$184,088	96,382	+6.1%	Shares	Defined	2025-05-13
2024-12-31	$321,664	90,866	+36.5%	Shares	Defined	2025-02-12
2024-09-30	$294,829	66,553	+51.2%	Shares	Defined	2024-11-12
2024-06-30	$174,350	44,028	-1.5%	Shares	Defined	2024-08-09
2024-03-31	$185,893	44,686	+234.6%	Shares	Defined	2024-05-13
2023-12-31	$38,192	13,354	0.0%	Shares	Defined	2024-02-13
2023-09-30	$35,521	13,354	—	Shares	Defined	2023-11-13
No filing history on record for this holder in this stock.